The ROE (Return on Equity) of Avadel Pharmaceuticals PLC (AVDL) is -66.13%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -66.13% |
| 2023-12-31 | -182.67% |
| 2022-12-31 | 650.10% |
| 2021-12-31 | -98.83% |
| 2020-12-31 | 4.33% |
| 2019-12-31 | 113.79% |
| 2018-12-31 | -3428.20% |
| 2017-12-31 | 79.77% |
| 2016-12-31 | -98.12% |
| 2015-12-31 | 60.46% |